David Drew MP attends APPG on Epilepsy event in Parliament on Purple Day
David Drew MP for Stroud, dressed in purple for an event at the All-Party Parliamentary Group (APPG) on Epilepsy to celebrate Purple Day, the international day of epilepsy awareness.
The group aims to raise awareness epilepsy among MPs and to engage with individuals and organisations in supporting the promotion of the needs of the epilepsy community.
The event was attended by many MPs from all parties, including the Chair of the APPG Paula Sherriff MP. They were joined by epilepsy charities Epilepsy Action, who are also the new secretariat of the APPG, The Epilepsy Society, Young Epilepsy and SUDEP Action. Attending MPs were given the opportunity to learn more about the condition and meet representatives from the charities.
Purple Day is held annually on 26 March and was created in 2008 by nine year old Cassidy Megan from Canada. People are encouraged to dress in purple on the day. MPs attending the APPG were given the chance to get into the Purple Day spirit by wearing purple for a photo at the end of the event.
David Drew MP commented: “It was fantastic to celebrate Purple Day with the APPG. I was very pleased to learn more about epilepsy and how the condition affects people.
“It was eye-opening to hear of the issues that some people with epilepsy face. From stigma and a lack of understanding about the condition to the problems people face with driving, employment and education.
“It is important that we continue to raise awareness about epilepsy and tackle the problems that people with the condition face.”
Philip Lee, chief executive of Epilepsy Action, said: “We are very pleased that so many MPs have attended the APPG on Epilepsy’s event to learn more about the condition this Purple Day.
“It is vitally important that MPs understand the impact that epilepsy has on 600,000 people in the UK and their families.
“We look forward to working with the APPG and MPs from all parties to improve the lives of everyone affected by epilepsy and improve access to high-quality, accessible epilepsy healthcare services.”